Katarina Lundh has been appointed as Business Development Director of Galena Pharma

August 7, 2025

Katarina Lundh will start in the position on 11.8.2025. She succeeds Atte Kukkonen, who will continue working with Galena Pharma as a member of board.

At Galena Pharma we are pleased to welcome Katarina to join our team as Business Development Director. Katarina, M.Sc. in Chemical Engineering, brings extensive industry experience to support Galena Pharma’s international growth journey. She has more than 30 years of experience in healthcare industry in roles among R&D and project management. Most of her career, Katarina has worked at Johnson & Johnson where her latest position was Global R&D Director of Digestive Healthcare. Katarina will report to the CEO and she joins the management team of Galena.


“We are thrilled to welcome Katarina Lundh to our team! Her deep industry knowledge and proven track record make her the ideal person to accelerate our next phase of international growth” says CEO Alexej von Bagh.


Previous long-time CEO and former Business Development Director, Atte Kukkonen, takes a place in the board of Galena Pharma. This is a planned transition and in addition to board work, Atte will support Galena Pharma’s operations as an advisor in selected projects.

Katarina Lundh

Further information:


Katarina Lundh

Business Development Director

firstname.lastname@galena.fi

Galena Pharma is a GMP- and EU MDR -certified pharmaceutical company specializing in manufacturing and developing substance-based medical devices. Galena Pharma provides its own ready-to-market MDR-approved medical devices for in-licensing as private label products. Our focus indication areas are gastrointestinal, female intimate care, cough & cold, pain and skin care.

Stay connected with us on LinkedIn for the latest industry news and updates!
Galena Pharma logo next to skincare products on a teal background.
August 5, 2025
We’re excited to announce that Galena Pharma will be attending several networking and partnering events across Europe during the second half of 2025. This is a great opportunity to connect with our team in person, explore potential collaborations, and learn more about our innovative medical devices. Join us at the following events: PharmaSynergy OTC on September 24-25 in Rome, to the event page click here CPHI on October 28-30 in Frankfurt, to the event page click here euroPLX by RauCon on November 24-25 in Berlin, to the event page click here About Galena Pharma Galena Pharma is a GMP- and MDR-certified pharmaceutical company specializing in the development and manufacturing of substance-based medical devices. We offer ready-to-market, MDR-approved medical devices available for in-licensing as a private label product. Our key focus areas include Gastrointestinal health, Female intimate care, Cough & cold, Pain relief and Skin care. Let’s meet and discuss how we can success together! More information and meeting appointments: Hrvoje Pervan, Sales Director, Central Europe hrvoje.pervan (at) galena.fi
April 29, 2025
During the spring of 2025, operations of Galena Pharma were re-certified to comply with the ISO 14001 environmental management system. As a result of the certification audit, we are pleased to announce that our operations consider environmental aspects with an excellent manner, and our renewed ISO 14001 certificate is now valid until 2028.
Green and blue capsules in clear plastic containers, orange background.
April 15, 2025
At the beginning of the year, we conducted a customer satisfaction survey to understand our customers’ experiences working with us during 2024. Based on the survey, we are proud to announce that our customers are extremely happy with the collaboration and they are highly willing to recommend Galena Pharma to their networks!